参考文献 References
[1] Ngan HYS, Seckl MJ, Berkowitz RS, et al. Update on the diagnosis and management of gestational trophoblastic disease [J]. International Journal of Gynecology and Obstetrics, 2018, 143(Supplement 2): 79-85.
[2] Altman AD, Bentley B, Murray S, et al. Maternal age-related rates of gestational trophoblastic disease [J]. Obstetrics and Gynecology, 2008, 112(2 Pt 1): 244-50.
[3] Eysbouts YK, Bulten J, Ottevanger PB, et al. Trends in incidence for gestational trophoblastic disease over the last 20 years in a population-based study [J]. Gynecologic oncology, 2016, 140(1): 70-5.
[4] Joneborg U, Folkvaljon Y. Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort study [J]. Acta oncologica (Stockholm, Sweden), 2018, 57(8): 1094-9.
[5] Smith HO, Wiggins C, Verschraegen CF, et al. Changing trends in gestational trophoblastic disease [J]. The Journal of Reproductive Medicine, 2006, 51(10): 777-84.
[6] Duff GB. Gestational trophoblastic disease in New Zealand, 1980-1986 [J]. The Australian & New Zealand Journal of Obstetrics &Gynaecology, 1989, 29(2): 139-42.
[7] Talati NJ. The pattern of benign gestational trophoblastic disease in Karachi [J]. JPMA The Journal of the Pakistan Medical Association, 1998, 48(10): 296-300.
[8] Aghababaii S, Shobeiri F, Hosseinipanah SM. Hydatidiform mole: A statistical survey in west of Iran [J]. Journal of Postgraduate Medical Institute, 2016, 30(1): 80-3.
[9] Harma M, Harma M, Yurtseven S, et al. Gestational trophoblastic disease in Sanliurfa, southeast Anatolia, Turkey [J].European Journal of Gynaecological Oncology, 2005, 26(3): 306-8.
[10] Yuk JS, Baek JC. Incidence of gestational trophoblastic disease in South Korea: a longitudinal, population-based study [J]. PeerJ, 2019, 7(e6490.
[11] Matsui H, Iitsuka Y, Yamazawa K, et al. Changes in the incidence of molar pregnancies. A population-based study in Chiba Prefecture and Japan between 1974 and 2000 [J]. Human reproduction (Oxford, England), 2003, 18(1): 172-5.
[12] Lurain JR. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole [J]. American Journal of Obstetrics and Gynecology, 2010, 203(6): 531-9.
[13] 全国绒癌协作组. 全国23个省、市、自治区二百余万妇女葡萄胎发病率调查初步总结 [J]. 中华医学杂志, 1980, 60(11): 641-4.
[14] 石一复, 李娟清, 郑伟, et al. 360余万次妊娠中妊娠滋养细胞疾病发生情况调查 [J]. 中华妇产科杂志, 2005, 40(2): 76-8.
[15] Ireson J, Singh K, Gillett S, et al. Evolution of a specialist gestational trophoblastic disease service with a major nursing component: the Sheffield, United Kingdom, experience [J]. The Journal of Reproductive Medicine, 2014, 59(5-6): 195-8.
[16] Kohorn E. Regional centers for trophoblastic disease [J]. American Journal of Obstetrics and Gynecology, 2007, 196(2): 95-6.
[17] Brewer JI, Eckman TR, Dolkart RE, et al. Gestational trophoblastic disease. A comparative study of the results of therapy in patients with invasive mole and with choriocarcinoma [J]. American Journal of Obstetrics and Gynecology, 1971, 109(2): 335-40.
[18] Hando T, Ohno M, Kurose T. Recent aspects of gestational trophoblastic disease in Japan [J]. International Journal of Gynaecology and Obstetrics, 1998, 60 Suppl 1(S71-6.
[19] Dantas PR, Maestá I, Cortés-Charry R, et al. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study [J]. The Journal of Reproductive Medicine, 2012, 57(7-8): 305-9.
[20] Kohorn EI. Worldwide survey of the results of treating gestational trophoblastic disease [J]. The Journal of Reproductive Medicine, 2014, 59(3-4): 145-53.
[21] 冯凤芝, 向阳, 贺豪杰, et al. 宫腔镜和腹腔镜在妊娠滋养细胞肿瘤鉴别诊断中的价值 [J]. 中华妇产科杂志, 2007, 42(7): 464-7.
[22] Hancock BW, Nazir K, Everard JE. Persistent gestational trophoblastic neoplasia after partial hydatidiform mole incidence and outcome [J]. The Journal of Reproductive Medicine, 2006, 51(10): 764-6.
[23] Fisher RA, Maher GJ. Genetics of gestational trophoblastic disease [J]. Best practice & research Clinical obstetrics & gynaecology, 2021, 74(29-41.
[24] Rozenholc A, Dodge J, Bréguet M, et al. Gestational Trophoblastic Disease: Opportunities for a National Registry Collaboration [J]. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2016, 26(6): 1182-5.
[25] Seckl MJ, Sebire NJ, Fisher RA, et al. Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J]. Annals of oncology : official journal of the European Society for Medical Oncology, 2013, 24 Suppl 6(vi39-50.
[26] Golfier F, Raudrant D, Frappart L, et al. First epidemiological data from the French Trophoblastic Disease Reference Center [J]. American journal of obstetrics and gynecology, 2007, 196(2): 172.e1-5.
[27] Clark LH, Staley SA, Barber EL, et al. The effect of distance traveled on disease outcomes in gestational trophoblastic neoplasia [J]. American journal of obstetrics and gynecology, 2016, 215(2): 217.e1-5.
[28] Braga A, Burlá M, Freitas F, et al. Centralized Coordination of Decentralized Assistance for Patients with Gestational Trophoblastic Disease in Brazil: A Viable Strategy for Developing Countries [J]. The Journal of reproductive medicine, 2016, 61(5-6): 224-9.